Vaccines Related News
Time for Europe to prioritise preventative health
Vaccine confidence has fallen to pre-pandemic levels but, says Sibilia Quilici, Executive Director of Vaccines Europe, there is a need and value in boosting...
Defence Therapeutics announces successful ARM-002TM cancer vaccine results
Defence Therapeutics has announced the successful testing of its second-generation anti-cancer vaccine, named ARM-002TM, utilising its flagship anti-cancer molecule, AccuTOX®.
The ARM-002TM cancer vaccine, when...
NHS launches MMR vaccine catch-up campaign
The NHS in England has embarked on a campaign to ensure that more than 900,000 adults aged 19 to 25 receive their missed MMR...
AstraZeneca to invest £650m in UK’s life sciences sector
Pharmaceutical giant AstraZeneca has revealed plans to inject £650m into the UK, bolstering the nation's life sciences sector and propelling economic growth.
This significant investment...
Challenges and opportunities for cervical screening and HPV vaccine uptake
Despite being one of the most preventable and treatable forms of cancer, many barriers to cervical cancer screening and HPV vaccine uptake exist. We...
Strengthening vaccination policies towards the European elections: From recommendations to concrete experiences
As the European elections approach, numerous policy recommendations are proposed on the priorities of the new institutions.
Yet, there is a risk of overlooking the...
The critical vaccine cold chain
Dr Nenad Miljković from the European Association of Hospital Pharmacists (EAHP) outlines the critical role of cold chain storage in maintaining the efficacy and...
mRNA vaccines: are they the way forward?
mRNA vaccine technology is broadening the scope of effective vaccine-based solutions that can mitigate the spread of harmful pathogens in infectious and non-infectious diseases.
For...
Developing mRNA vaccine technology
Following the unprecedented development of vaccines during the COVID-19 pandemic, we spoke to Dinah Knotts about mRNA vaccine technology and what further opportunities it...
NHS winter vaccination programme breaks flu and COVID-19 jab records
The NHS winter vaccination programme in England has accomplished an extraordinary milestone by delivering more than ten million flu vaccinations and over seven million...
Correctly transporting pharmaceutical products and biospecimens to ensure patient safety and scientific accuracy
The transportation and storage of biospecimens and pharmaceuticals have become increasingly important in the healthcare industry.
These sensitive materials, ranging from tissue samples to life-saving...
Over one million NHS Covid vaccines administered in one week
The NHS has delivered more than one million Covid vaccines over the last week. Find out if you're eligible for a vaccine.
Cold chain challenges solved with collaboration
B Medical Systems has hosted a roundtable event at Medlab Asia – providing insights into the challenges of cold chain systems.
During the Medlab Asia...
Sepsis prevention: The alliance of vaccinations, sanitation, and the vaccine cold chain
Sepsis is a severe bodily reaction to infection, which can cause fever, breathlessness, disorientation, tissue damage, and organ failure, among other symptoms.
While bacterial infections...
UK and BioNTech SE sign landmark deal for cancer vaccine trials
The UK Government has established a historic agreement with German-based BioNTech SE for cancer vaccine trials.
The groundbreaking deal will improve access to cancer vaccine...
Defence Therapeutics granted US patent for vaccine enhancer technology
Discover how the issue of a patent will allow Defence Therapeutics' vaccine enhancer technology to be commercialised.
Defence Therapeutics’ mRNA cancer vaccine testing begins
Canadian biopharmaceutical specialist Defence Therapeutics has announced that testing of its revolutionary AccumTM-linked mRNA cancer vaccine has started.
The performance of Defence’s AccumTM mRNA cancer...
Clinical trial finds temperature-stable TB vaccine safe and effective
A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found it was safe.
A phase 1 trial, supported by the...
Defence advances to phase I clinical trials of the Accum technology
Defence Therapeutics Inc. is pleased to update its stakeholders on its completed achievements and outline the future milestones for AccumTM set for 2023.
Over the...
NICE recommends three treatments for COVID-19
The National Institute for Health and Care Excellence (NICE) has recommended three treatments for COVID-19 that are cost-effective.
Everyone with COVID-19 at the highest risk...